Friday, August 15th, 2008
Talley Medical’s Negative Pressure Wound Therapy products are now available on Drug Tariff
Read the article »
Wednesday, July 16th, 2008
Talley Group receive FDA clearance to market Venturi™ system in the United States
Read the article »
Monday, June 23rd, 2008
Venturi™ Negative Pressure Wound Therapy products awarded onto NHS Supply Chain Contract
Read the article »
TECare® is a highly effective and ultra safe antimicrobial product. The unique physical action of the chemical matrix prevents further colonisation and the formation of biofilms on treated surfaces for up to 4 weeks.